Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dyphylline measurement |
Has measured component |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline measurement |
Component |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dyphylline 250mg/2cc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline 160mg/15ml elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline 100mg/15mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline 200mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely diprophylline 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 100mg/100mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 100mg/100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 100mg/100mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 100mg/50mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 200mg/100mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing diprophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing diprophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Parenteral dyphylline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dyphylline+guaifenesin 100mg/100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diprophylline- and guaifenesin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dyphylline 200mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dyphylline 200mg (product) |
Has basis of strength substance (attribute) |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dyphylline + guaifenesin 200mg/100mg capsule |
Has basis of strength substance (attribute) |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dyphylline + guaifenesin 200mg/100mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dyphylline + guaifenesin 200mg/100mg capsule |
Has basis of strength substance (attribute) |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dyphylline 200mg (product) |
Has precise active ingredient |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
Has precise active ingredient |
False |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diprophylline 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing diprophylline and guaifenesin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dyphylline + guaifenesin 200mg/100mg capsule |
Has precise active ingredient |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diprophylline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only diprophylline and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only diprophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only diprophylline and guaifenesin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only diprophylline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diprophylline 10.7 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diprophylline 10.7 mg/mL oral solution |
Has precise active ingredient |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
Has precise active ingredient |
True |
Diprophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |